QTTB Q32 Bio Inc. - Common Stock
$15,38
Harga · Agu 18, 2026
Fundamental per Agu 5, 2026
Rentang 52M
$2–$24
63% of range
Peringkat Analis
BUY
11 analysts
Target Harga
$43
+178% upside
P/E (TTM)
6.4
ROE
200.3%
Margin Laba Bersih
55.5%
QTTB Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$15.38
Kapitalisasi Pasar
$198M
P/E (TTM)
6.4
EPS (TTM)
$2.42
Pendapatan (TTM)
$54M
Imbal Hasil Dividen
—
ROE
200.3%
D/E Utang/Ekuitas
—
Rentang 52M
$2 – $24
QTTB Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
$54M
2018-12-31
→
2025-12-31
EPS
$2.42
2021-12-31
→
2025-12-31
Arus Kas Bebas
$-34M
2018-12-31
→
2025-12-31
Margin
55.5%
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
QTTB
Median Rekan
P/E (TTM)
6.4
16.6
P/S (TTM)
3.7
9.4
P/B
4.7
2.4
Price / FCF (Harga / FCF)
-5.9
—
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
QTTB
Median Rekan
Operating Margin (Margin Operasi)
31.4%
—
Net Profit Margin (Margin Laba Bersih)
55.5%
-298.0%
ROA
38.7%
-38.4%
ROE
200.3%
-63.7%
ROIC
40.2%
—
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
QTTB
Median Rekan
Current Ratio (Rasio Lancar)
4.9
3.9
Quick Ratio (Rasio Cepat)
4.3
—
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
QTTB
Median Rekan
Revenue CAGR 3Y (CAGR Pendapatan 3T)
155.9%
—
Revenue CAGR 5Y (CAGR Pendapatan 5T)
81.8%
—
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
QTTB
Median Rekan
QTTB Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
BELI
11 analis
- Beli Kuat 3 27,3%
- Beli 7 63,6%
- Tahan 1 9,1%
- Jual 0 0,0%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
4 analis · 2026-08-18
Median
$38.00
Rata-rata
$42.75
← Di bawah semua target
$15.38
Rendah
$36.00
Tinggi
$59.00
Target median
$38.00
+147,0%
Target rata-rata
$42.75
+177,9%
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
1.00%
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 30 Juni 2026 | $-0.44 | $-0.55 | 0.11% |
| 31 Maret 2026 | $-0.54 | $-0.69 | 0.15% |
| 31 Des. 2025 | $3.65 | $-0.88 | 4.5% |
| 30 Sep. 2025 | $-0.60 | $-1.21 | 0.61% |
| 30 Juni 2025 | $-0.78 | $-1.00 | 0.22% |
| 31 Maret 2025 | $-0.90 | $-1.25 | 0.35% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| QTTB | $43M | 1.4 | — | 55.5% | 200.3% | — |
| ZURA | — | — | — | — | — | — |
| EVMN | $540M | -1.5 | 85.7% | -529.8% | -401.2% | — |
| CCCC | $185M | -1.5 | 1.0% | -292.1% | -48.8% | — |
| MPLT | $773M | -0.9 | — | — | -151.1% | — |
| CABA | $220M | -1.0 | — | — | -115.5% | — |
| OCGN | $422M | -5.6 | 8.8% | -1537.4% | 1488.8% | — |
| LRMR | $317M | -2.2 | — | — | -167.4% | — |
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | — |
| RZLT | $388M | -4.6 | — | — | -56.9% | — |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 14
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $54M | $0 | $-7M | $3M | $34M | $3M | $2M | $5M | |
| R&D Expense | $19M | $48M | $32M | $98M | $93M | $100M | $89M | $48M | |
| SG&A Expense | $18M | $18M | $10M | $38M | $37M | $33M | $22M | $17M | |
| Operating Expenses | $37M | $66M | $42M | $136M | $130M | $133M | $112M | $65M | |
| Operating Income | $17M | $-66M | $-48M | $-133M | $-96M | $-130M | $-110M | $-60M | |
| Other Non-op | $1M | $4M | $1M | $134M | $185.0K | $2M | $6M | $4M | |
| Pretax Income | $30M | $-46M | $-53M | $1M | $-96M | · | · | · | |
| Income Tax | $0 | $21.0K | $318.0K | $715.0K | $0 | $0 | $0 | $0 | |
| Net Income | $30M | $-48M | $-54M | $-5M | $-96M | $-129M | $-104M | $-56M | |
| EPS (Basic) | $2.42 | $-5.12 | $-153.96 | $-0.09 | $-1.73 | · | · | · | |
| EPS (Diluted) | $2.42 | $-6.58 | $-153.96 | $-0.09 | $-1.73 | · | · | · | |
| Shares (Basic) | 12,300,568 | 9,320,884 | 349,060 | 57,399,762 | 55,283,318 | · | · | · | |
| Shares (Diluted) | 12,314,796 | 9,657,696 | 349,060 | 57,399,762 | 55,283,318 | · | · | · | |
| EBITDA | $17M | $-66M | · | $-133M | $-96M | $-130M | $-110M | $-62M |
Neraca 23
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $48M | $78M | $26M | $34M | $108M | $217M | $54M | $38M | |
| Short-term Investments | · | $0 | $0 | $141M | · | · | · | · | |
| Prepaid Expense | $7M | $4M | $3M | $6M | $7M | $2M | $4M | $7M | |
| Other Current Assets | $20.0K | $396.0K | $83.0K | · | · | · | · | · | |
| Current Assets | $55M | $82M | $29M | $181M | $192M | $220M | $267M | $222M | |
| PP&E (Net) | $979.0K | $1M | $2M | $1M | $2M | $37M | $43M | $36M | |
| PP&E (Gross) | $3M | $3M | $3M | $7M | $8M | $53M | $51M | $38M | |
| Accum. Depreciation | $2M | $1M | $966.0K | $6M | $6M | $16M | $8M | $2M | |
| Other Non-current Assets | $0 | $116.0K | $5M | · | · | · | · | · | |
| Total Assets | $62M | $92M | $47M | $228M | $212M | $264M | $311M | $259M | |
| Accounts Payable | $879.0K | $3M | $3M | $1M | $2M | $5M | $3M | $16M | |
| Accrued Liabilities | $4M | $7M | $10M | · | · | · | · | · | |
| Current Liabilities | $11M | $16M | $14M | $23M | $17M | $23M | $12M | $23M | |
| Capital Leases | $5M | $6M | $6M | $28M | $24M | $13M | · | · | |
| Other Non-current Liabilities | $0 | $55M | $55M | · | · | · | · | · | |
| Total Liabilities | $20M | $87M | $119M | $50M | $42M | $68M | $52M | $63M | |
| Common Stock | $2.0K | $2.0K | $1.0K | $6.0K | $6.0K | $5.0K | $4.0K | $3.0K | |
| Paid-in Capital | $247M | $240M | $4M | $608M | · | · | · | · | |
| Retained Earnings | $-205M | $-235M | $-187M | $-429M | $-424M | $-328M | $-200M | $-96M | |
| AOCI | · | $0 | $0 | $-404.0K | $-7.0K | $0 | $183.0K | $-77.0K | |
| Stockholders' Equity | $42M | $6M | $-183M | $-131M | $170M | $196M | $259M | $196M | |
| Liabilities + Equity | $62M | $92M | $47M | $228M | $212M | $264M | $311M | $259M | |
| Shares Outstanding | 12,858,047 | 12,197,615 | 359,569 | 57,483,910 | 57,150,274 | 50,265,575 | 45,116,742 | 37,358,526 |
Arus Kas 11
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $5M | $4M | $1M | $13M | $17M | $13M | $8M | $3M | |
| Deferred Tax | · | $100.0K | $300.0K | · | · | · | · | · | |
| Restructuring | · | · | $10M | · | · | · | · | · | |
| Operating Cash Flow | $-34M | $-68M | $-19M | $-114M | $-110M | $-94M | $-91M | $-43M | |
| CapEx | $0 | $75.0K | $5.0K | $1M | $2M | $4M | $22M | $25M | |
| Investing Cash Flow | $7M | $20M | $-5.0K | $37M | $-51M | $205M | $-52M | $-122M | |
| Stock Issued | $0 | $42M | $0 | $0 | $50M | · | $135M | · | |
| Net Stock Activity | $0 | $42M | · | $0 | $50M | · | $135M | · | |
| Financing Cash Flow | $-3M | $95M | $406.0K | $596.0K | $52M | $53M | $158M | $151M | |
| Net Change in Cash | · | · | $5M | $-76M | $-108M | $164M | $15M | $-13M | |
| Free Cash Flow | $-34M | $-68M | · | $-115M | $-112M | $-98M | $-113M | $-68M |
Profitabilitas 7
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 31.4% | · | · | -4154.6% | -282.4% | -4821.0% | -6599.2% | -1671.1% | |
| Net Margin | 55.5% | · | · | -156.0% | -281.9% | -4762.9% | -6237.4% | -1553.1% | |
| Pretax Margin | 55.5% | · | · | 37.3% | · | · | · | · | |
| EBITDA Margin | 31.4% | · | · | -4154.6% | -282.4% | -4821.0% | -6599.2% | -1671.1% | |
| ROA | 38.7% | -68.5% | · | -2.3% | -40.3% | -44.8% | -36.5% | -28.8% | |
| ROE | 200.3% | -398.3% | · | -2.6% | -52.0% | -70.3% | -40.2% | -28.0% | |
| ROIC | 40.2% | -1165.3% | · | -30.2% | · | · | · | · |
Likuiditas & Solvabilitas 2
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.9 | 5.0 | · | 8.0 | 11.1 | 9.7 | 21.5 | 8.7 | |
| Quick Ratio | 4.3 | 4.7 | · | 1.5 | 6.3 | 9.6 | 4.3 | 1.5 |
Efisiensi 1
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.0 | · | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 |
Tingkat Pertumbuhan 3
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | -90.6% | 1157.2% | · | · | · | |
| Revenue CAGR 3Y | 155.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 81.8% | · | · | · | · | · | · | · |
Valuasi (TTM) 10
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $54M | $0 | $-7M | $3M | $34M | $3M | $2M | $5M | |
| Net Income TTM | $30M | $-48M | $-54M | $-5M | $-96M | $-129M | $-104M | $-56M | |
| Market Cap | $43M | $42M | · | $1.30B | $3.74B | $10.21B | $16.81B | $15.04B | |
| P/E | 1.4 | -0.5 | -0.1 | -252.0 | -37.9 | · | · | · | |
| P/S | 0.8 | · | · | 406.4 | 110.2 | 3780.5 | 10090.3 | 2825.3 | |
| P/B | 1.0 | 7.4 | · | 7.3 | 22.1 | 52.1 | 65.0 | 77.2 | |
| P / Tangible Book | 1.0 | 7.4 | · | · | 22.1 | 52.1 | · | · | |
| P / Cash Flow | -1.3 | -0.6 | · | -11.5 | -34.1 | -108.3 | -184.0 | -353.3 | |
| P / FCF | -1.3 | -0.6 | · | -11.3 | -33.4 | -104.2 | -148.5 | -222.8 | |
| Earnings Yield | 72.9% | -191.3% | -1406.8% | -0.40% | -2.6% | · | · | · |
Laporan Laba Rugi 14
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $-15M | $2M | $3M | $3M | $802.0K | $802.0K | |
| R&D Expense | $4M | $3M | $3M | $4M | $5M | $7M | $11M | $14M | $13M | $10M | $8M | $7M | $8M | $8M | $27M | $26M | |
| SG&A Expense | $5M | $5M | $5M | $4M | $4M | $5M | $4M | $4M | $5M | $5M | $3M | $2M | $2M | $2M | $8M | $8M | |
| Operating Expenses | $9M | $8M | $8M | $8M | $9M | $12M | $15M | $19M | $18M | $15M | $11M | $10M | $10M | $10M | $35M | $34M | |
| Operating Income | $-9M | $-8M | $46M | $-8M | $-9M | $-12M | $-15M | $-19M | $-18M | $-15M | $-26M | $-8M | $-7M | $-7M | $-34M | $-33M | |
| Other Non-op | $319.0K | $113.0K | $115.0K | $188.0K | $-318.0K | $1M | $358.0K | $1M | $2M | $158.0K | $196.0K | $84.0K | $165.0K | $578.0K | $1M | $1M | |
| Pretax Income | · | · | $58M | $-7M | $-9M | $-11M | $-14M | $-18M | $-16M | $1M | $-27M | $-14M | $-6M | $-7M | $-33M | $-32M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $21.0K | $0 | $0 | $0 | $383.0K | $-65.0K | $0 | $0 | $-403.0K | $46.0K | |
| Net Income | $-9M | $-8M | $58M | $-7M | $-9M | $-11M | $-14M | $-18M | $-17M | $1M | $-27M | $-14M | $-6M | $-7M | $-34M | $-34M | |
| EPS (Basic) | $-0.44 | $-0.54 | $4.70 | $-0.60 | $-0.78 | $-0.90 | $-3.27 | $-1.46 | $-1.42 | $1.03 | $-76.91 | $-40.52 | $-16.69 | $-19.84 | $-0.60 | $-0.59 | |
| EPS (Diluted) | $-0.44 | $-0.54 | $4.70 | $-0.60 | $-0.78 | $-0.90 | $2.63 | $-1.46 | $-1.42 | $-6.33 | $-76.91 | $-40.52 | $-16.69 | $-19.84 | $-0.58 | $-0.59 | |
| Shares (Basic) | 20,342,345 | 14,095,371 | -24,335,204 | 12,240,542 | 12,197,615 | 12,197,615 | -15,715,032 | 12,076,412 | 11,964,224 | 995,280 | -689,787 | 346,288 | 347,936 | 344,623 | -114,712,971 | 57,447,192 | |
| Shares (Diluted) | 20,342,345 | 14,095,371 | -24,320,976 | 12,240,542 | 12,197,615 | 12,197,615 | -16,717,120 | 12,076,412 | 11,964,224 | 2,334,180 | -689,787 | 346,288 | 347,936 | 344,623 | -115,308,584 | 57,447,192 | |
| EBITDA | $-9M | $-8M | · | $-8M | $-9M | $-12M | · | $-19M | $-18M | $-15M | · | $-31M | $-31M | $-28M | · | $-33M |
Neraca 23
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $106M | $51M | $48M | $49M | $55M | $65M | $78M | $89M | $98M | $116M | $26M | $29M | $77M | $39M | $34M | $43M | |
| Short-term Investments | · | · | · | · | · | · | · | $0 | · | · | $0 | $74M | $50M | $111M | · | · | |
| Prepaid Expense | $3M | $6M | $7M | $2M | $3M | $3M | $4M | $5M | $4M | $3M | $3M | $3M | $4M | $4M | $6M | $12M | |
| Other Current Assets | $19.0K | $20.0K | $20.0K | $24.0K | $77.0K | $93.0K | $396.0K | $229.0K | $51.0K | $67.0K | $83.0K | · | · | · | · | · | |
| Current Assets | $110M | $57M | $55M | $51M | $58M | $69M | $82M | $94M | $112M | $138M | $29M | $107M | $131M | $154M | $181M | $213M | |
| PP&E (Net) | $804.0K | $889.0K | $979.0K | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $0 | $845.0K | $1M | $1M | $1M | |
| PP&E (Gross) | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $0 | $7M | $7M | $7M | $8M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $966.0K | $0 | $7M | $6M | $6M | $7M | |
| Other Non-current Assets | · | · | $0 | $0 | $570.0K | $444.0K | $116.0K | $40.0K | $1M | $1M | $5M | · | · | · | · | · | |
| Total Assets | $116M | $64M | $62M | $58M | $66M | $79M | $92M | $105M | $124M | $152M | $47M | $140M | $169M | $198M | $228M | $263M | |
| Accounts Payable | $2M | $653.0K | $879.0K | $973.0K | $910.0K | $3M | $3M | $1M | $2M | $5M | $3M | $8M | $3M | $4M | $1M | $5M | |
| Accrued Liabilities | $4M | $4M | $4M | $4M | $4M | $5M | $7M | $9M | $11M | $20M | $10M | · | · | · | · | · | |
| Current Liabilities | $5M | $11M | $11M | $11M | $12M | $15M | $16M | $14M | $17M | $33M | $14M | $25M | $23M | $19M | $23M | $25M | |
| Capital Leases | $5M | $5M | $5M | $5M | $5M | $5M | $6M | $6M | $6M | $6M | $6M | $27M | $27M | $27M | $28M | $28M | |
| Other Non-current Liabilities | · | · | $0 | $55M | $55M | $55M | $55M | $55M | $55M | $55M | $55M | · | · | · | · | · | |
| Total Liabilities | $10M | $17M | $20M | $76M | $78M | $83M | $87M | $86M | $91M | $104M | $119M | $52M | $50M | $46M | $50M | $54M | |
| Common Stock | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | |
| Paid-in Capital | $327M | $259M | $247M | $244M | $243M | $242M | $240M | $239M | $237M | $235M | $4M | $614M | $612M | $610M | · | · | |
| Retained Earnings | $-222M | $-213M | $-205M | $-263M | $-255M | $-246M | $-235M | $-221M | $-203M | $-186M | $-187M | $-526M | $-493M | $-458M | $-429M | $-395M | |
| AOCI | · | · | · | $0 | $0 | $0 | · | $-1.0K | $-1.0K | $-5.0K | $0 | $-36.0K | $-88.0K | $-182.0K | $-404.0K | $-457.0K | |
| Stockholders' Equity | $106M | $46M | $42M | $-18M | $-12M | $-4M | $6M | $18M | $34M | $49M | $-183M | $88M | $119M | $152M | $178M | $209M | |
| Liabilities + Equity | $116M | $64M | $62M | $58M | $66M | $79M | $92M | $105M | $124M | $152M | $47M | $140M | $169M | $198M | $228M | $263M | |
| Shares Outstanding | 23,736,600 | 14,629,463 | 12,858,047 | 12,304,352 | 12,197,615 | 12,197,615 | 12,197,615 | 12,138,869 | 11,995,206 | 11,929,520 | 359,569 | 57,902,210 | 57,798,133 | 57,794,767 | 57,483,910 | 57,480,610 |
Arus Kas 10
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $417.0K | $521.0K | $-4M | $-2M | $296.0K | $3M | $3M | |
| Restructuring | · | · | · | $0 | $0 | $900.0K | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-3M | $-6M | $-6M | $-4M | $-11M | $-12M | $-11M | $-20M | $-22M | $-15M | $-11M | $42M | $2M | $-12M | $-27M | $-25M | |
| CapEx | · | · | $0 | $0 | · | · | $2.0K | $58.0K | $15.0K | $0 | $0 | $-223.0K | $-224.0K | $5.0K | $9.0K | $6.0K | |
| Investing Cash Flow | $0 | $0 | $7M | $0 | $0 | $0 | $-2.0K | $10M | $10M | $97.0K | $0 | $-92M | $-31M | $-5.0K | $18M | $-108M | |
| Stock Issued | $0 | $10M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $42M | $0 | $0 | $0 | $0 | · | · | |
| Net Stock Activity | · | $10M | · | · | · | $0 | · | · | · | $42M | · | · | · | · | · | · | |
| Financing Cash Flow | $59M | $9M | $-2M | $-2M | · | · | $317.0K | $997.0K | $-6M | $99M | $76.0K | $178.0K | $-120.0K | $15.0K | $32.0K | $124.0K | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | · | · | $-48M | $37M | $5M | $-9M | $-133M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-15M | · | · | · | $-26M | · | · |
Profitabilitas 7
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3706.5% | 4021.9% | · | 3444.1% | 3229.2% | 3296.0% | · | · | · | · | · | · | -8705.1% | -3430.3% | · | -4097.5% | |
| Net Margin | 3636.6% | 3963.0% | · | 3358.6% | 3341.2% | 2973.3% | · | · | · | · | · | · | -9899.4% | -3596.5% | · | -4205.2% | |
| Pretax Margin | · | · | · | 3358.6% | 3341.2% | 2973.3% | · | · | · | · | · | · | -8278.2% | -3247.1% | · | -3939.3% | |
| EBITDA Margin | 3706.5% | 4021.9% | · | 3444.1% | 3229.2% | 3296.0% | · | · | · | · | · | · | -8705.1% | -3430.3% | · | -4097.5% | |
| ROA | -9.8% | -10.7% | · | -9.1% | -10.0% | -9.5% | · | -14.4% | -11.6% | 0.59% | · | -16.4% | -15.4% | -11.3% | · | -13.7% | |
| ROE | -19.1% | -36.0% | · | 9658.8% | -89.2% | -49.3% | · | -33.0% | -22.2% | 1.0% | · | -22.2% | -19.5% | -13.8% | · | -16.6% | |
| ROIC | · | · | · | 41.1% | 75.0% | 304.6% | · | -102.8% | -53.5% | -30.4% | · | -35.1% | -25.8% | -18.1% | · | -15.7% |
Likuiditas & Solvabilitas 2
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 20.3 | 5.4 | · | 4.6 | 5.1 | 4.7 | · | 6.5 | 6.5 | 4.2 | · | 4.2 | 5.7 | 8.3 | · | 8.4 | |
| Quick Ratio | 19.7 | 4.8 | · | 4.4 | 4.8 | 4.5 | · | 6.2 | 5.7 | 3.5 | · | 4.1 | 5.5 | 8.1 | · | 1.7 |
Efisiensi 1
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | -0.0 | -0.0 | · | -0.0 | -0.0 | -0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Valuasi (TTM) 10
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | · | $2M | $2M | $2M | · | $2M | $5M | $8M | · | $9M | $8M | $5M | · | $4M | |
| Net Income TTM | $-33M | $-36M | · | $-46M | $-55M | $-45M | · | $-48M | $-36M | $-26M | · | $-60M | $-75M | $22M | · | $-1M | |
| Market Cap | $302M | $94M | · | $24M | $18M | $20M | · | $542M | $215M | $203M | · | $1.22B | $921M | $1.07B | · | $1.67B | |
| P/E | -5.4 | -2.3 | · | -0.5 | -0.3 | -0.2 | · | -0.9 | -0.3 | -0.2 | · | -0.3 | -0.4 | -1.0 | · | -579.6 | |
| P/S | 162.7 | 50.5 | · | 13.1 | 9.8 | 10.8 | · | 291.4 | 42.5 | 25.4 | · | 138.4 | 118.7 | 200.2 | · | 408.0 | |
| P/B | 2.9 | 2.0 | · | -1.3 | -1.5 | -5.0 | · | 29.6 | 6.4 | 4.2 | · | 13.8 | 7.7 | 7.1 | · | 8.0 | |
| P / Tangible Book | 2.9 | 2.0 | · | · | · | · | · | 29.6 | 6.4 | 4.2 | · | 13.8 | 7.7 | 7.1 | · | 8.0 | |
| P / Cash Flow | · | -14.8 | · | · | · | -1.6 | · | · | · | -14.0 | · | · | · | -41.1 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | -14.0 | · | · | · | -40.8 | · | · | |
| Earnings Yield | -18.5% | -43.9% | · | -188.9% | -306.0% | -612.7% | · | -111.5% | -361.9% | -489.3% | · | -368.7% | -236.2% | -104.4% | · | -0.17% |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Laporan Laba Rugi
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Pendapatan | $54M | $0 | $-7M | $3M | $34M |
| Margin Operasi % | 31.4% | — | — | -4154.6% | -282.4% |
| Laba Bersih | $30M | $-48M | $-54M | $-5M | $-96M |
| EPS Dilusian | $2.42 | $-6.58 | $-153.96 | $-0.09 | $-1.73 |
Neraca
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Rasio Lancar | 4.9 | 5.0 | — | 8.0 | 11.1 |
| Rasio Cepat | 4.3 | 4.7 | — | 1.5 | 6.3 |
Arus Kas
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-34M | $-68M | — | $-115M | $-112M |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 77 pengaju · $280.5M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 33 (+25 vs Kuartal sebelumnya) | 8 (0 vs Kuartal sebelumnya) | 14 (+1 vs Kuartal sebelumnya) | 14 (+4 vs Kuartal sebelumnya) | +13.3M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | $52.590.554 | 4.127.987 | 18,75% | Saham |
| Boxer Capital Management, LLC | $40.122.209 | 3.149.310 | 14,30% | Saham |
| Atlas Venture Life Science Advisors, LLC | $34.615.930 | 2.717.106 | 12,34% | Saham |
| BVF INC/IL | $29.939.000 | 2.350.000 | 10,67% | Saham |
| RA CAPITAL MANAGEMENT, L.P. | $29.715.502 | 2.332.457 | 10,59% | Saham |
| Point72 Asset Management, L.P. | $14.949.065 | 1.173.396 | 5,33% | Saham |
| Opaleye Management Inc. | $11.860.940 | 931.000 | 4,23% | Saham |
| Logos Global Management LP | $10.192.000 | 800.000 | 3,63% | Saham |
| SummitTX Capital, L.P. | $9.348.281 | 733.774 | 3,33% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $6.609.550 | 518.803 | 2,36% | Saham |
| Ikarian Capital, LLC | $5.478.200 | 430.000 | 1,95% | Saham |
| Woodline Partners LP | $3.646.341 | 286.212 | 1,30% | Saham |
| AMERICAN CENTURY COMPANIES INC | $3.474.860 | 272.752 | 1,24% | Saham |
| Sanofi | $3.109.617 | 244.083 | 1,11% | Saham |
| ACORN CAPITAL ADVISORS, LLC | $2.754.019 | 216.171 | 0,98% | Saham |
| Ikarian Capital, LLC | $2.548.000 | 200.000 | 0,91% | Opsi jual |
| RENAISSANCE TECHNOLOGIES LLC | $2.288.104 | 179.600 | 0,82% | Saham |
| JANE STREET GROUP, LLC | $1.686.164 | 132.352 | 0,60% | Saham |
| MONIMUS CAPITAL MANAGEMENT, LP | $1.682.139 | 132.036 | 0,60% | Saham |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.661.640 | 130.427 | 0,59% | Saham |
| CITADEL ADVISORS LLC | $1.537.247 | 120.663 | 0,55% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $1.273.455 | 99.923 | 0,45% | Saham |
| MARSHALL WACE, LLP | $854.153 | 67.045 | 0,30% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $843.605 | 66.217 | 0,30% | Saham |
| BOOTHBAY FUND MANAGEMENT, LLC | $780.962 | 61.300 | 0,28% | Opsi jual |
| Carlyle Group Inc. | $769.020 | 60.363 | 0,27% | Saham |
| STATE STREET CORP | $665.206 | 52.214 | 0,24% | Saham |
| TWO SIGMA INVESTMENTS, LP | $631.675 | 49.582 | 0,23% | Saham |
| Quadrature Capital Ltd | $463.685 | 36.396 | 0,17% | Saham |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $440.970 | 34.613 | 0,16% | Saham |
| DAFNA Capital Management LLC | $419.095 | 32.896 | 0,15% | Saham |
| Knott David M Jr | $387.449 | 30.412 | 0,14% | Saham |
| Affinity Asset Advisors, LLC | $353.879 | 27.777 | 0,13% | Saham |
| Squarepoint Ops LLC | $303.085 | 23.790 | 0,11% | Saham |
| NORTHERN TRUST CORP | $301.059 | 23.631 | 0,11% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $297.377 | 23.342 | 0,11% | Saham |
| MANGROVE PARTNERS IM, LLC | $282.191 | 22.150 | 0,10% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $255.857 | 20.083 | 0,09% | Saham |
| LPL Financial LLC | $231.486 | 18.170 | 0,08% | Saham |
| UBS Group AG | $183.698 | 14.419 | 0,07% | Saham |
| Balyasny Asset Management L.P. | $157.237 | 12.342 | 0,06% | Saham |
| ExodusPoint Capital Management, LP | $144.421 | 11.336 | 0,05% | Saham |
| MILLENNIUM MANAGEMENT LLC | $139.223 | 10.928 | 0,05% | Saham |
| XTX Topco Ltd | $138.535 | 10.874 | 0,05% | Saham |
| Vanguard Global Advisers, LLC | $61.458 | 4.824 | 0,02% | Saham |
| Nuveen Asset Management, LLC | $54.758 | 15.918 | 0,02% | Saham |
| MORGAN STANLEY | $54.132 | 4.249 | 0,02% | Saham |
| FMR LLC | $43.163 | 3.388 | 0,02% | Saham |
| CITIGROUP INC | $36.793 | 2.888 | 0,01% | Saham |
| BlackRock, Inc. | $25.047 | 1.966 | 0,01% | Saham |
| Private Wealth Asset Management, LLC | $21.658 | 1.700 | 0,01% | Saham |
| Arax Advisory Partners | $14.154 | 1.111 | 0,01% | Saham |
| FEDERATED HERMES, INC. | $13.377 | 1.050 | 0,00% | Saham |
| Rockefeller Capital Management L.P. | $7.351 | 577 | 0,00% | Saham |
| JONES FINANCIAL COMPANIES LLLP | $6.585 | 500 | 0,00% | Saham |
| VANGUARD GROUP INC | $6.358 | 1.915 | 0,00% | Saham |
| Russell Investments Group, Ltd. | $5.784 | 454 | 0,00% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $3.860 | 303 | 0,00% | Saham |
| EverSource Wealth Advisors, LLC | $3.058 | 240 | 0,00% | Saham |
| ACADIAN ASSET MANAGEMENT LLC | $2.779 | 218.234 | 0,00% | Saham |
| NISA INVESTMENT ADVISORS, LLC | $2.115 | 166 | 0,00% | Saham |
| Truvestments Capital LLC | $2.064 | 162 | 0,00% | Saham |
| OSAIC HOLDINGS, INC. | $1.579 | 124 | 0,00% | Saham |
| Allworth Financial LP | $1.376 | 108 | 0,00% | Saham |
| SBI Securities Co., Ltd. | $1.198 | 94 | 0,00% | Saham |
| Clearstead Advisors, LLC | $854 | 67 | 0,00% | Saham |
| Caitong International Asset Management Co., Ltd | $573 | 45 | 0,00% | Saham |
| Federation des caisses Desjardins du Quebec | $484 | 38 | 0,00% | Saham |
| GROUP ONE TRADING LLC | $433 | 34 | 0,00% | Saham |
| CWM, LLC | $250 | 39 | 0,00% | Saham |
| Cambridge Investment Research Advisors, Inc. | $230 | 18.081 | 0,00% | Saham |
| HRT FINANCIAL LP | $203 | 15.949 | 0,00% | Saham |
| HARBOUR INVESTMENTS, INC. | $140 | 11 | 0,00% | Saham |
| MERCER GLOBAL ADVISORS INC /ADV | $25 | 2 | 0,00% | Saham |
| AdvisorNet Financial, Inc | $25 | 2 | 0,00% | Saham |
| DANSKE BANK A/S | $13 | 1 | 0,00% | Saham |
| ROYAL BANK OF CANADA | $0 | 28 | 0,00% | Saham |
Orang dalam perusahaan 29 orang dalam · 13 pejabat · 18 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Jodie Pope Morrison | CEO | 16 Juli 2026 A | 353.104 | 0 | 3 | $-141.391 |
| Albert Seymour | President and Chief Executive Officer | 6 Sep. 2023 M | 150.874 | 0 | 0 | $0 |
| Lee Kalowski | CFO and President | 16 Juli 2026 A | 142.443 | 0 | 3 | $-57.038 |
| Paul Alloway | Former President and Chief Operating Officer of Homology Medicines, Inc. | 25 Maret 2024 S | 2.596 | 0 | 0 | $0 |
| Timothy P Kelly | Chief Operating Officer | 24 Feb. 2022 A | 2.224 | 0 | 0 | $0 |
| Siyamak Rasty | Chief Operating Officer | 9 Juli 2019 S | 222.707 | 0 | 0 | $0 |
| Shelia M. Violette | Chief Scientific Officer | 16 Juli 2026 A | 130.569 | 0 | 2 | $-18.078 |
| Jason Campagna | Chief Medical Officer | 24 Feb. 2025 A | 37.500 | 0 | 0 | $0 |
| Charles Michaud Jr | Former Vice President, Corporate Controller and Treasurer of Homology Medicines, Inc. | 25 Maret 2024 S | 927 | 0 | 0 | $0 |
| Julie Jordan | Chief Medical Officer | 3 Agu 2023 M | 7.496 | 0 | 0 | $0 |
| Michael Lee Blum | Chief Commercial Officer | 23 Feb. 2023 A | 13.538 | 0 | 0 | $0 |
| Bradford W Smith | Chief Financial and Business Officer and Treasurer | 23 Feb. 2023 A | 14.219 | 0 | 0 | $0 |
| Gabriel Cohn | Chief Medical Officer | 1 Jan. 2022 M | 2.629 | 0 | 0 | $0 |
| Diyong Xu | Direktur | 12 Juni 2026 A | 625.000 | 2 | 0 | $15.000.000 |
| David S. Grayzel | Direktur | 12 Juni 2026 A | — | 0 | 0 | $0 |
| Sven Ante Lundberg | Direktur | 12 Juni 2026 A | — | 0 | 0 | $0 |
| Isaac Manke | Direktur | 12 Juni 2026 A | 53.521 | 0 | 0 | $0 |
| Arthur Tzianabos | Direktur | 12 Juni 2026 A | 7.983 | 0 | 0 | $0 |
| Mark T Iwicki | Direktur | 12 Juni 2026 A | — | 0 | 0 | $0 |
| Mary Thistle | Direktur | 12 Juni 2026 A | — | 0 | 0 | $0 |
| Kathleen Laporte | Direktur | 12 Juni 2026 A | — | 0 | 0 | $0 |
| Jeffrey V. Poulton | Direktur | 14 Juni 2023 A | — | 0 | 0 | $0 |
| Alise Reicin | Direktur | 14 Juni 2023 A | — | 0 | 0 | $0 |
| Matthew R Patterson | Direktur | 14 Juni 2023 A | — | 0 | 0 | $0 |
| Steven Gillis | Direktur | 14 Juni 2023 A | 6.068.695 | 0 | 0 | $0 |
| Kush Parmar | Direktur | 15 Juni 2022 A | 181.435 | 0 | 0 | $0 |
| Richard J. Gregory | Direktur | 15 Juni 2022 A | 10.806 | 0 | 0 | $0 |
| Cameron Wheeler | Direktur | 6 Juni 2019 A | — | 0 | 0 | $0 |
| Mahendra Shah | Direktur | 2 April 2018 A | 909.742 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Aktivis & pemilik 5%+ 4 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP VII LLC, OrbiMed Genesis GP LLC ×5 pengajuan | 20 Juli 2026 | 13,90% | Amandemen | — | SEC |
| Atlas Venture Fund X, L.P., ATLAS VENTURE ASSOCIATES X, L.P., Atlas Venture Associates X, LLC, Atlas Venture Opportunity Fund I, L.P., Atlas Venture Associates Opportunity I, L.P., Atlas Venture Associates Opportunity I, LLC, Atlas Venture Opportunity Fund II, L.P., Atlas Venture Associates Opportunity II, L.P., Atlas Venture Associates Opportunity II, LLC, Atlas Venture Opportunity Fund Ill, L.P., Atlas Venture Associates Opportunity III, L.P., Atlas Venture Associates Opportunity III, LLC ×2 pengajuan | 28 Mei 2026 | 3,60% | Amandemen | — | SEC |
| Acorn Bioventures, L.P., Acorn Capital Advisors, GP, LLC, Anders Hove | 4 April 2024 | — | Pengajuan awal | M&A / penjualan | SEC |
| Deerfield Mgmt III, L.P., Deerfield Private Design Fund III, L.P., Deerfield Healthcare Innovations Fund, L.P., Deerfield Mgmt HIF, L.P., Deerfield Management Company, L.P., James E. Flynn ×5 pengajuan | 1 Mei 2020 | — | Pengajuan awal | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Kepemilikan ETF Dimiliki oleh 8 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,70% | 10.132 SH | 8 Agu 2026 | Harian |
| IWC · iShares Trust | 0,03% | 29.465 SH | 8 Agu 2026 | Harian |
| AVUV · AMERICAN CENTURY ETF TRUST | 0,01% | 128.510 NS | 31 Mei 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 14.652 NS | 30 April 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 314 NS | 31 Mei 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 119.269 SH | 8 Agu 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 389.115 SH | 8 Agu 2026 | Harian |
| DFSV · Dimensional ETF Trust | 0,00% | 490 NS | 30 April 2026 | N-PORT |